Sinopharm Tech Holdings (HKSE:08156) Days Sales Outstanding : 0.00 (As of Dec. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings Days Sales Outstanding?

Sinopharm Tech Holdings's average Accounts Receivable for the three months ended in Dec. 2024 was HK$17.65 Mil. Sinopharm Tech Holdings's Revenue for the three months ended in Dec. 2024 was HK$0.00 Mil.

The historical rank and industry rank for Sinopharm Tech Holdings's Days Sales Outstanding or its related term are showing as below:

HKSE:08156' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.58 Med: 161.52 Max: 838.01
Current: 838.01

During the past 13 years, Sinopharm Tech Holdings's highest Days Sales Outstanding was 838.01. The lowest was 46.58. And the median was 161.52.

HKSE:08156's Days Sales Outstanding is ranked worse than
98.61% of 2735 companies
in the Software industry
Industry Median: 63.06 vs HKSE:08156: 838.01

Sinopharm Tech Holdings's Days Sales Outstanding declined from Jun. 2023 (32.00) to Dec. 2024 (0.00).

Sinopharm Tech Holdings Days Sales Outstanding Historical Data

The historical data trend for Sinopharm Tech Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings Days Sales Outstanding Chart

Sinopharm Tech Holdings Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Days Sales Outstanding

Get a 7-Day Free Trial

46.58

86.05

190.28

155.55

124.36

Sinopharm Tech Holdings Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial															32.00	185.08	580.56	-	-

Competitive Comparison of Sinopharm Tech Holdings's Days Sales Outstanding

For the Software - Application subindustry, Sinopharm Tech Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinopharm Tech Holdings's Days Sales Outstanding Distribution in the Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Sinopharm Tech Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Sinopharm Tech Holdings's Days Sales Outstanding for the fiscal year that ended in Jun. 2024 is calculated as

	Days Sales Outstanding (A: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (8.095	+	20.032)	/	2 )	/	41.277	*	365
=	14.0635					/	41.277	*	365
=	124.36

Sinopharm Tech Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (20.032	+	15.262)	/	2 )	/	0	*	365 / 4
=	17.647					/	0	*	365 / 4
=	N/A

Sinopharm Tech Holdings (HKSE:08156) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Sinopharm Tech Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Tech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18th Floor, Ruttonjee House, Hong Kong Central, Hong Kong, HKG

Website

https://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Internet Plus services; Supply chain services; and Manufacturing and distribution of personal protective equipment. It generates maximum revenue from Supply chain services segment, which includes provision of supply chain management, data analysis and related services and trading of related goods, and trading of medial and related products. Geographically, it derives a majority of revenue from Hong Kong.

Executives

Chiu Sin Nang Kenny	2201 Interest of corporation controlled by you
Creative Big Limited	2101 Beneficial owner
Integrated Asset Management (asia) Limited	2101 Beneficial owner
Yam Tak Cheung	2201 Interest of corporation controlled by you
Quantum Worldwide Investment Limited	2101 Beneficial owner
Best Frontier Investments Limited
Chan Kin Ho Philip	2201 Interest of corporation controlled by you
Lam Yui Keung	2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited	2101 Beneficial owner
Main Key Investments Limited	2201 Interest of corporation controlled by you
Guo Lei	2201 Interest of corporation controlled by you
Chan Tung Mei	2202 Interest of your spouse
Cheung Kwai Lan	2201 Interest of corporation controlled by you
Tse Siu Hoi	2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.)	2102 Investment manager

Sinopharm Tech Holdings Headlines

No Headlines